Page last updated: 2024-08-23

epirubicin and Cardiac Output, Low

epirubicin has been researched along with Cardiac Output, Low in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caron, HN; Kremer, LC; Michiels, EM; van Dalen, EC	3
Bonneterre, J; Catimel, G; Dieras, V; Dumortier, A; Garet, F; Graffand, N; Guastalla, JP; Kayitalire, L; Pellae-Cosset, B; Pouillart, P; Spielmann, M; Tubiana-Hulin, M	1
Hopewell, JW; Simmonds, RH; Yeung, TK	1

Reviews

3 review(s) available for epirubicin and Cardiac Output, Low

Article	Year
Different anthracycline derivates for reducing cardiotoxicity in cancer patients. The Cochrane database of systematic reviews, 2010, Mar-17, Issue:3 Topics: Adult; Antibiotics, Antineoplastic; Cardiac Output, Low; Child; Doxorubicin; Epirubicin; Heart; Humans; Liposomes; Neoplasms; Randomized Controlled Trials as Topic	2010
Different anthracycline derivates for reducing cardiotoxicity in cancer patients. The Cochrane database of systematic reviews, 2010, May-12, Issue:5 Topics: Adult; Antibiotics, Antineoplastic; Cardiac Output, Low; Child; Doxorubicin; Epirubicin; Heart; Humans; Liposomes; Neoplasms; Randomized Controlled Trials as Topic	2010
Different anthracycline derivates for reducing cardiotoxicity in cancer patients. The Cochrane database of systematic reviews, 2006, Oct-18, Issue:4 Topics: Adult; Antibiotics, Antineoplastic; Cardiac Output, Low; Child; Doxorubicin; Epirubicin; Heart; Humans; Liposomes; Neoplasms; Randomized Controlled Trials as Topic	2006

Trials

1 trial(s) available for epirubicin and Cardiac Output, Low

Article	Year
Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience. Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiac Output, Low; Cyclophosphamide; Epirubicin; Female; France; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel	1997

Article

Year

Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.

Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiac Output, Low; Cyclophosphamide; Epirubicin; Female; France; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel

1997

Other Studies

1 other study(ies) available for epirubicin and Cardiac Output, Low

Article	Year
The relative toxicity of intravenous and intraperitoneal doses of epirubicin. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4 Topics: Animals; Cardiac Output; Cardiac Output, Low; Dose-Response Relationship, Drug; Epirubicin; Heart; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Male; Myocardium; Rats; Rats, Inbred Strains; Time Factors; Weight Loss	1989